KINGDON CAPITAL MANAGEMENT, L.L.C. - Q1 2020 holdings

$546 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 52 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .

 Value Shares↓ Weighting
BHVN ExitBIOHAVEN PHARMACTL HLDG CO Lcall$0-300
-100.0%
-0.00%
MAS ExitMASCO CORP$0-9,648
-100.0%
-0.07%
XLP ExitSELECT SECTOR SPDR TRsbi cons stpls$0-9,800
-100.0%
-0.09%
REGN ExitREGENERON PHARMACEUTICALS$0-1,901
-100.0%
-0.11%
ExitKEMPHARM INCnote 5.500% 2/0$0-3,000,000
-100.0%
-0.18%
ARQL ExitARQULE INCcall$0-100,000
-100.0%
-0.30%
AUPH ExitAURINIA PHARMACEUTICALS INCcall$0-100,000
-100.0%
-0.30%
ATNX ExitATHENEX INCcall$0-150,000
-100.0%
-0.34%
IOVA ExitIOVANCE BIOTHERAPEUTICS INCput$0-100,000
-100.0%
-0.42%
LSCC ExitLATTICE SEMICONDUCTOR CORP$0-156,791
-100.0%
-0.45%
PVG ExitPRETIUM RES INC$0-345,889
-100.0%
-0.58%
HUYA ExitHUYA INC$0-229,484
-100.0%
-0.62%
GDI ExitGARDNER DENVER HLDGS INC$0-218,000
-100.0%
-1.20%
FAST ExitFASTENAL CO$0-270,000
-100.0%
-1.50%
UNP ExitUNION PACIFIC CORP$0-58,008
-100.0%
-1.58%
MOMO ExitMOMO INCadr$0-339,149
-100.0%
-1.71%
XLC ExitSELECT SECTOR SPDR TRput$0-225,000
-100.0%
-1.82%
MDCO ExitMEDICINES COput$0-150,000
-100.0%
-1.92%
GSAH ExitGS ACQUISITION HLDGS CORP$0-1,347,647
-100.0%
-2.24%
ERI ExitELDORADO RESORTS INC$0-530,401
-100.0%
-4.76%
XBI ExitSPDR SERIES TRUSTput$0-350,000
-100.0%
-5.01%
SPY ExitSPDR S&P 500 ETF TRput$0-200,000
-100.0%
-9.70%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (546251000.0 != 546252000.0)

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings